Abstract N6‐methyladenosine (m6A) is an RNA modification involved in RNA processing
and widely found in transcripts. In cancer cells, m6A is upregulated, contributing to their …

Pancreatic cancer (PC) is one of the most common malignant cancers, ranking the seventh
highest causes of cancer-related deaths globally. Recently, RNA N6-methyladenosine …

Abstract N 6-methyladenosine (m 6 A), the most abundant RNA modification in eukaryotes,
plays a pivotal role in regulating many cellular and biological processes. Aberrant m 6 A …

Accumulating evidence has demonstrated that N6-methyladenosine (m6A) plays important
roles in various cancers, making it essential to profile m6A modifications at a transcriptome …

N6-methyladenosine (m6A) is the most abundant internal modification on eukaryotic
mRNAs. There is increasing evidence that m6A plays a key role in tumor progression, so it is …

Abstract Background N6-methyladenosine (m6A) is a prevalent and crucial RNA methylation
modification that plays a significant role in various biological and pathological processes …

Aim: To comprehensively profile the landscape of the mRNA N6-methyladenosine (m6A)
modification in human colorectal cancer (CRC). Methods: Methylated RNA …

Background Pancreatic cancer is one of the most lethal human cancers. N 6-
methyladenosine (m 6 A), a common eukaryotic mRNA modification, plays critical roles in …

N 6-methyladenosine (m6A) is the most abundant epitranscriptome modification in
mammalian mRNA. Recent years have seen substantial progress in m6A epitranscriptomics …

Background: N6-methyladenosine (m6A) is the most prevalent modification of mammalian
RNA. Emerging evidence suggest that m6A has critical roles in multiple biological activities …